PlumX Metrics
Embed PlumX Metrics

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

International Journal of Molecular Sciences, ISSN: 1422-0067, Vol: 25, Issue: 4
2024
  • 5
    Citations
  • 0
    Usage
  • 8
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    5
  • Captures
    8
  • Mentions
    2
    • Blog Mentions
      1
      • Blog
        1
    • News Mentions
      1
      • News
        1

Most Recent News

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.

Int J Mol Sci. 2024 Feb 18;25(4) Authors: Beghini DG, Kasai-Brunswick TH, Henriques-Pons A PubMed: 38397069 Submit Comment

Review Description

Induced pluripotent stem cells (iPSCs) are derived from reprogrammed adult somatic cells. These adult cells are manipulated in vitro to express genes and factors essential for acquiring and maintaining embryonic stem cell (ESC) properties. This technology is widely applied in many fields, and much attention has been given to developing iPSC-based disease models to validate drug discovery platforms and study the pathophysiological molecular processes underlying disease onset. Especially in neurological diseases, there is a great need for iPSC-based technological research, as these cells can be obtained from each patient and carry the individual’s bulk of genetic mutations and unique properties. Moreover, iPSCs can differentiate into multiple cell types. These are essential characteristics, since the study of neurological diseases is affected by the limited access to injury sites, the need for in vitro models composed of various cell types, the complexity of reproducing the brain’s anatomy, the challenges of postmortem cell culture, and ethical issues. Neurodegenerative diseases strongly impact global health due to their high incidence, symptom severity, and lack of effective therapies. Recently, analyses using disease specific, iPSC-based models confirmed the efficacy of these models for testing multiple drugs. This review summarizes the advances in iPSC technology used in disease modelling and drug testing, with a primary focus on neurodegenerative diseases, including Parkinson’s and Alzheimer’s diseases.

Bibliographic Details

Beghini, Daniela Gois; Kasai-Brunswick, Tais Hanae; Henriques-Pons, Andrea

MDPI AG

Chemical Engineering; Biochemistry, Genetics and Molecular Biology; Chemistry; Computer Science

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know